Vaccines for preventing rotavirus diarrhoea: vaccines in use

K Soares‐Weiser, H Bergman… - Cochrane database …, 2019 - cochranelibrary.com
Background Rotavirus results in more diarrhoea‐related deaths in children under five years
than any other single agent in countries with high childhood mortality. It is also a common …

Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors

DE Velasquez, U Parashar, B Jiang - Expert review of vaccines, 2018 - Taylor & Francis
Introduction: Numerous studies have shown that the oral rotavirus vaccines are less effective
in infants born in low income countries compared to those born in developed countries …

Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity

L Pöyhönen, J Bustamante, JL Casanova… - Journal of clinical …, 2019 - Springer
Live-attenuated vaccines (LAVs) can protect humans against 12 viral and three bacterial
diseases. By definition, any clinical infection caused by a LAV that is sufficiently severe to …

Vaccines for preventing rotavirus diarrhoea: vaccines in use

H Bergman, N Henschke, D Hungerford… - Cochrane Database …, 2021 - cochranelibrary.com
Background Rotavirus is a common cause of diarrhoea, diarrhoea‐related hospital
admissions, and diarrhoea‐related deaths worldwide. Rotavirus vaccines prequalified by …

Impfen bei Immundefizienz

S Ehl, C Bogdan, T Niehues, G Burchard… - Bundesgesundheitsblatt …, 2018 - Springer
Impfen bei Immundefizienz | SpringerLink Skip to main content Advertisement SpringerLink
Log in Menu Find a journal Publish with us Search Cart 1.Home 2.Bundesgesundheitsblatt …

Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC)

MLA de Hoog, T Vesikari, C Giaquinto, HI Huppertz… - 2018 - Taylor & Francis
ABSTRACT The Fifth European Expert Meeting on Rotavirus Vaccination was convened in
Utrecht, The Netherlands, in March 2017. The 2-day meeting included invited lectures as …

Established and new rotavirus vaccines: a comprehensive review for healthcare professionals

V Vetter, RC Gardner, S Debrus… - Human vaccines & …, 2022 - Taylor & Francis
Robust scientific evidence related to two rotavirus (RV) vaccines available worldwide
demonstrates their significant impact on RV disease burden. Improving RV vaccination …

Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: A randomised, double-blind, four-arm …

D Witte, A Handley, KC Jere… - The Lancet Infectious …, 2022 - thelancet.com
Background Rotavirus vaccines reduce rotavirus-related deaths and hospitalisations but are
less effective in high child mortality countries. The human RV3-BB neonatal G3P [6] rotavirus …

Dilemmas with rotavirus vaccine: the neonate and immunocompromised

M Chiu, C Bao, M Sadarangani - The Pediatric Infectious Disease …, 2019 - journals.lww.com
Rotavirus (RV) is the leading cause of severe gastroenteritis in young children. However,
because the incorporation of live-attenuated RV vaccines as part routine childhood …

Suboptimal vaccination administration in mothers with inflammatory bowel disease and their biologic-exposed infants

H Chiarella-Redfern, S Lee, B Jubran… - Inflammatory Bowel …, 2022 - academic.oup.com
Background Pregnant women with inflammatory bowel disease (IBD) are at increased risk of
developing complications from vaccine-preventable infections. We investigated the factors …